Vanqua Bio last raised $45.0M in its Early Stage VC (Feb 2024).
- ·The complete investor list: 12 names
- ·Watch Vanqua Bio: the Monday email on marks, rounds and moves
Vanqua Bio funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Feb 2024 | Early Stage VC | $45.0M | ▮ | ▮ |
| Aug 2021 | Later Stage VC | $85.0M | ▮ | ▮ |
Membership and data by Private Market View
Vanqua Bio valuation
Vanqua Bio's last known valuation is $270 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
How much has Vanqua Bio raised?
Vanqua Bio has raised $149 million across 2 recorded rounds since 2021. The largest was an $85 million later-stage round in Aug 2021; the most recent was a $45 million early-stage round in Feb 2024.
Vanqua Bio has filed 2 Form Ds with the SEC since 2021, most recently in Jul 2024 ($45 million sold to 12 investors).
How Vanqua Bio's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Vanqua Bio, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about Vanqua Bio
- What is Vanqua Bio worth?
- Vanqua Bio's last known valuation is $270.0M.
- How much has Vanqua Bio raised?
- Vanqua Bio has raised $149.0M in total funding across 2 recorded rounds.
- When did Vanqua Bio last raise?
- Vanqua Bio last raised in Feb 2024 (Early Stage VC), raising $45.0M.